Medicine for treating post-chemotherapy leucopenia and preparation method thereof

Abstract

The invention discloses a medicine for treating post-chemotherapy leucopenia and a preparation method thereof. The medicine consists of the following raw materials in part by weight: 2 to 20 parts of ginseng, 5 to 50 parts of astragalus, 5 to 50 parts of gensing, 5 to 50 parts of largehead atractylodes rhizome, 5 to 30 parts of epimedium, 5 to 20 parts of malaytea scurfpea fruit, 5 to 30 parts ofChinese angelica, 5 to 50 parts of suberect spatholobus stem, 5 to 50 parts of medlar, 5 to 30 parts of dwarf lilyturf tuber, 3 to 25 parts of bupleurum, 3 to 35 parts of largetrifoliolious bugbane rhizome and 1 to 15 parts of pangolin scales. According to the preparation method, the Chinese medicinal composition is prepared according to a method for the conventional preparation of Chinese medicines, wherein the conventional preparation comprises a water decoction, an oral liquid, granules, capsules or powder and the like. According to the medicine, a prescription for treating post-chemotherapy leucopenia is created on the basis of clinical experiences of multiple years, and a curative effect is obvious.

Description

technical field [0001] The invention relates to a medicine and a preparation method thereof, in particular to a medicine for treating malignant tumor patients with leukopenia after chemotherapy by using Chinese herbal medicine as a raw material and a preparation method thereof. Background technique [0002] Chemotherapy is one of the main methods for the treatment of malignant tumors. It can inhibit and kill cancer cells, but it also has a strong killing effect on normal cells and tissues, especially the destruction of bone marrow hematopoietic cells, so that the normal hematopoietic function of bone marrow cannot be restored. , resulting in decreased leukocytes, multiple infections, decreased resistance of patients, and inability to tolerate chemotherapy. Therefore, it is particularly important to protect the hematopoietic function of the bone marrow, increase the number of white blood cells, and reduce the damage of chemotherapy and cancer toxins to the hematopoietic syste...

AI Technical Summary

Problems solved by technology

In recent years, colony-stimulating factors are often used as adjuvant therapy for the treatment of leukopenia caused by chemotherapy drugs. These drugs have significant curative effects but are relatively expensive, with short acting time, unstable curative effect, and relatively large side effects. For example, colony-stimulating factors can cause In addition to side effects such as bone pain, flu-like symptoms, fever, and leukopenia after drug withdrawal, it may also stimulate the growth of certain malignant cells, which limits clinical application to a certain extent

In addition, there are other treatments such as hormone therapy, but the disadvantage is that the curative effect is unreliable and it is easy to induce infection; oral administration of vitamins, batyl alcohol, and leucogen has poor curative effect; a small amount of multiple white blood cell transfusion or whole blood transfusion has the disadvantage of high cost, The operation is complicated, and the blood transfusion itself has certain risks. The survival time of the transfused leukocytes in the body is short, and the blood source is currently scarce.

At present, Western medicine lacks specific drugs with good effect on post-chemotherapy leukopenia

Images